4-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)benzonitrile, 95+%, 5g

1-Benzyl-5-methylpyrrolidin-2-one, 95%, 100mg

Ciclopentano, min 95%, per sintesi, 10 l, conf.

Ethyl 2-bromo-3-fluorobenzoate, 250mg

4-Bromo-2-fluoropyridine-3-carboxaldehyde, 95.0%, 25g

H-D-Cys(Bzl)-OH, 95.0%, 1g

(S)-1-N-Boc-3-Methylaminopiperidine, 95.0%, 250mg

N,N,N-Trimethyl-1-(pyridin-2-yl)methanaminium iodide, 95%, 100mg

1H-Benzo[d]imidazole-4-carbaldehyde, 95.0%, 500mg

(3R,4S)-4-(2-Cyclopropylethyl)-3-(methoxymethoxy)-1-(4-methoxyphenyl)azetidin-2-one, 98%, 1g

Ethyl 2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate, 95.0%, 100mg

N-(4-CHLOROBENZYL)-N-(2,2-DIMETHOXYETHYL)-4-METHYLBENZENESULFONAMIDE, 95.0%, 100mg

1-(6-(2-Bromophenoxy)pyridin-3-yl)ethanone, 95%, 1g